4ed0bea5-figure-01 (4ed0bea5 Figure 01)
Tizanidine
Product Images NDC 58517-380
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 58517-380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by New Horizon Rx Group, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
4ed0bea5-figure-02 (4ed0bea5 Figure 02)
Plasma tizanidine concentration can be measured in ng/mL after ingesting different formulations of 4 mg tizanidine tablets or capsules with or without food. The data is presented in a table with time (hours from dosing) and different letters indicating the treatment groups. No further information is provided.*
4ed0bea5-figure-03 (4ed0bea5 Figure 03)
4ed0bea5-figure-04 (4ed0bea5 Figure 04)
4ed0bea5-figure-05 (4ed0bea5 Figure 05)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
